ImmuCell (ICCC) Competitors $6.48 -0.04 (-0.61%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$6.51 +0.03 (+0.46%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICCC vs. BTMD, NBTX, PRQR, SLRN, TVGN, MNPR, SXTC, SLS, EDIT, and DSGNShould you be buying ImmuCell stock or one of its competitors? The main competitors of ImmuCell include biote (BTMD), Nanobiotix (NBTX), ProQR Therapeutics (PRQR), Acelyrin (SLRN), Semper Paratus Acquisition (TVGN), Monopar Therapeutics (MNPR), China SXT Pharmaceuticals (SXTC), SELLAS Life Sciences Group (SLS), Editas Medicine (EDIT), and Design Therapeutics (DSGN). These companies are all part of the "pharmaceutical products" industry. ImmuCell vs. Its Competitors biote Nanobiotix ProQR Therapeutics Acelyrin Semper Paratus Acquisition Monopar Therapeutics China SXT Pharmaceuticals SELLAS Life Sciences Group Editas Medicine Design Therapeutics ImmuCell (NASDAQ:ICCC) and biote (NASDAQ:BTMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership. Is ICCC or BTMD more profitable? biote has a net margin of 10.93% compared to ImmuCell's net margin of -1.00%. ImmuCell's return on equity of -1.02% beat biote's return on equity.Company Net Margins Return on Equity Return on Assets ImmuCell-1.00% -1.02% -0.61% biote 10.93%-19.44%20.12% Which has more risk & volatility, ICCC or BTMD? ImmuCell has a beta of 0.32, meaning that its share price is 68% less volatile than the S&P 500. Comparatively, biote has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. Do insiders & institutionals hold more shares of ICCC or BTMD? 13.5% of ImmuCell shares are owned by institutional investors. Comparatively, 21.7% of biote shares are owned by institutional investors. 6.6% of ImmuCell shares are owned by insiders. Comparatively, 24.0% of biote shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings and valuation, ICCC or BTMD? biote has higher revenue and earnings than ImmuCell. ImmuCell is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmuCell$26.49M2.21-$2.16M-$0.07-92.57biote$197.19M1.13$3.16M$0.616.69 Does the media prefer ICCC or BTMD? In the previous week, ImmuCell had 3 more articles in the media than biote. MarketBeat recorded 4 mentions for ImmuCell and 1 mentions for biote. biote's average media sentiment score of 1.19 beat ImmuCell's score of 0.99 indicating that biote is being referred to more favorably in the news media. Company Overall Sentiment ImmuCell Positive biote Positive Do analysts recommend ICCC or BTMD? biote has a consensus price target of $8.00, suggesting a potential upside of 96.08%. Given biote's stronger consensus rating and higher probable upside, analysts plainly believe biote is more favorable than ImmuCell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImmuCell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00biote 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Summarybiote beats ImmuCell on 13 of the 16 factors compared between the two stocks. Get ImmuCell News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICCC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICCC vs. The Competition Export to ExcelMetricImmuCellMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$58.56M$10.47B$5.56B$9.11BDividend YieldN/A2.08%5.06%4.01%P/E Ratio-92.5617.1228.2620.26Price / Sales2.2129.96435.95101.33Price / Cash100.7822.5637.1257.67Price / Book2.103.668.045.49Net Income-$2.16M$235.43M$3.19B$250.45M7 Day Performance-3.50%1.27%3.62%4.78%1 Month PerformanceN/A5.34%5.98%9.58%1 Year Performance50.70%-15.78%29.39%16.41% ImmuCell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICCCImmuCell0.2434 of 5 stars$6.48-0.6%N/A+50.7%$58.56M$26.49M-92.5670News CoverageBTMDbiote3.2392 of 5 stars$3.99-5.5%$8.00+100.5%-49.6%$230.88M$199.38M6.54194Positive NewsNBTXNanobiotix2.8017 of 5 stars$4.75-2.5%$8.00+68.6%-7.2%$229.54M$39.18M0.00100PRQRProQR Therapeutics2.5457 of 5 stars$2.14-1.8%$8.00+273.8%+25.4%$229.36M$20.46M-6.11180Analyst ForecastSLRNAcelyrinN/A$2.27flat$9.60+322.9%N/A$229.17MN/A-0.92135TVGNSemper Paratus Acquisition4.0395 of 5 stars$1.20-3.2%$10.00+733.3%+66.4%$228.03MN/A0.003Positive NewsMNPRMonopar Therapeutics2.0297 of 5 stars$37.20+2.6%$60.00+61.3%+936.1%$221.68MN/A-10.6910Analyst RevisionSXTCChina SXT Pharmaceuticals0.9363 of 5 stars$1.69-10.1%N/A-82.9%$218.13M$1.93M0.0090Gap DownSLSSELLAS Life Sciences Group0.3387 of 5 stars$2.17flatN/A+58.6%$216.52M$1M-5.7110High Trading VolumeEDITEditas Medicine4.2532 of 5 stars$2.54-1.2%$4.70+85.0%-48.0%$215.14M$32.31M-0.84230Positive NewsDSGNDesign Therapeutics0.6325 of 5 stars$3.54-6.1%$4.00+13.0%-10.1%$214.02MN/A-3.5840News CoveragePositive News Related Companies and Tools Related Companies BTMD Alternatives NBTX Alternatives PRQR Alternatives SLRN Alternatives TVGN Alternatives MNPR Alternatives SXTC Alternatives SLS Alternatives EDIT Alternatives DSGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICCC) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuCell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ICCC Stock Alerts